Format

Send to

Choose Destination
J Paediatr Child Health. 2000 Oct;36(5):449-52.

Hepatic glycogenosis: reversible hepatomegaly in type 1 diabetes.

Author information

1
Department of Endocrinology, Royal Children's Hospital, Herston, Queensland, Australia. Munnsc@health.qld.gov.au

Abstract

OBJECTIVE:

To describe the aetiology, clinical features and appropriate treatment for hepatic glycogenosis in poorly controlled type 1 diabetes.

METHODS:

A review of three adolescents with poor diabetes control, hepatomegaly and elevated serum liver transaminase concentrations.

RESULTS:

Symptoms included abdominal pain, anorexia, nausea and vomiting. All had tender hepatomegaly; two had splenomegaly. Liver biopsy was performed on two patients. Histology revealed hepatic glycogenosis in both; one also demonstrated macrovesicular steatosis. With improved glycaemic control, all three showed resolution of their symptoms, organomegaly and elevated serum liver transaminase concentrations.

CONCLUSIONS:

Insulin-reversible hepatic glycogenosis is the most common cause of hepatomegaly and raised serum liver transaminase concentrations in children and adolescents with type 1 diabetes. Having excluded other causes of hepatic dysfunction, a 4 week therapeutic trial of improved glycaemic control is recommended prior to more invasive investigations.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center